News
EBS
1.920
-1.54%
-0.030
FDA approves Amneal's generic version of OTC Narcan
FDA approves Amneal Pharmaceuticals’ OTC Naloxone HCl nasal spray, a generic version of the opioid overdose medication OTC Narcan. Narcan is marketed by drugmaker Emergent Biosolutions. Bausch Health filed a patent infringement suit against the company earlier this month.
Seeking Alpha · 2d ago
BUZZ-Amneal gains on FDA approval of over-the-counter overdose reversal nasal spray
Amneal Pharmaceuticals up 11% premarket on FDA approval of over-the-counter overdose reversal spray. Amneal's spray is a generic version of Narcan spray approved in 2023 to be sold without a prescription. Company's shares up 11%. Shares of AMRX down 11% YTD.
Reuters · 2d ago
Weekly Report: what happened at EBS last week (0415-0419)?
Weekly Report · 4d ago
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
Emergent BioSolutions Inc. Will host a conference call on Wednesday, May 1, 2024, to discuss the financial results for the first quarter 2024. The company will also discuss key business updates and revenue guidance for the second quarter of 2024. EBS will host the conference call at 5:00 p.m.
Barchart · 4d ago
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 11% drop adds to one-year losses
Institutional investors own 79% of Emergent BioSolutions Inc. (NYSE:EBS) The company has a high level of institutional ownership. 51% of the business is held by the top 12 shareholders of the company. The company's share price fell by 11% last week. BlackRock, Inc. Is the largest shareholder of the firm. Emergent bioSolutions has a history of growing revenue but not earnings. We look at the shareholders of Emergent Biosolutions to see how the company has changed.
Simply Wall St · 04/15 11:34
Weekly Report: what happened at EBS last week (0408-0412)?
Weekly Report · 04/15 09:14
BUZZ-U.S. STOCKS ON THE MOVE-DoorDash, Devon Energy, Arvinas
DoorDash, Devon Energy, Arvinas among top Nasdaq percentage gainers. Softer-than-anticipated producer prices data soothed investor fears about sticky inflation. Dow e-minis were up 0.08% in premarket trading. The Nasdaq eyed a higher open on Thursday.
Reuters · 04/11 13:39
Emergent Biosolutions Price Target Maintained With a $5.00/Share by Benchmark
Dow Jones · 04/11 13:15
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $5 Price Target
Benzinga · 04/11 13:05
BUZZ-U.S. STOCKS ON THE MOVE-Rallybio, Alpine Immune, Marcus
U.S. Stock index futures dip on Thursday as Treasury yields remain elevated. Top three NYSE percentage gainers premarket: Rallybio, Alpine Immune, Marcus. Top 3 Nasdaq percentage losers: Carmax, Fastenal and Marcus. Dow e-minis were down 0.33% at 7:32 ET.
Reuters · 04/11 11:47
Analysts’ Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)
TipRanks · 04/11 11:20
Weekly Report: what happened at EBS last week (0401-0405)?
Weekly Report · 04/08 09:15
AQUESTIVE THERAPEUTICS STRENGTHENS BOARD OF DIRECTORS WITH EXPERIENCED BIOTECH EXECUTIVE
Reuters · 04/01 12:00
AQUESTIVE THERAPEUTICS INC - BOARD OF DIRECTORS WILL NOW BE COMPRISED OF EIGHT DIRECTORS
Reuters · 04/01 12:00
Weekly Report: what happened at EBS last week (0325-0329)?
Weekly Report · 04/01 09:15
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Emergent BioSolutions Inc. Is committed to fighting the ongoing opioid crisis. In 2022, the CDC reported over 107,000 overdose deaths in the U.S. The company's NARCAN Nasal Spray is designed to help save lives in opioid overdose emergencies.
Barchart · 03/28 07:15
Weekly Report: what happened at EBS last week (0318-0322)?
Weekly Report · 03/25 09:15
Weekly Report: what happened at EBS last week (0311-0315)?
Weekly Report · 03/18 09:15
Weekly Report: what happened at EBS last week (0304-0308)?
Weekly Report · 03/11 09:14
BUZZ-U.S. STOCKS ON THE MOVE-Teladoc Health, Hamilton Insurance, SciSparc
Wall Street's main indexes gained on Thursday. Dow Jones Industrial Average was up 0.50% at 38,855.19. Federal Reserve chair Jerome Powell said the central bank still expects to cut rates later this year. The top three S&P 500 percentage gainers were ON Semiconductor, The Kroger. Victoria's Secret & Co. Was the biggest loser.
Reuters · 03/07 19:02
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.